Literature DB >> 20431112

Genetics of osteoporosis.

Stuart H Ralston1, André G Uitterlinden.   

Abstract

Osteoporosis is a common disease with a strong genetic component characterized by reduced bone mass, defects in the microarchitecture of bone tissue, and an increased risk of fragility fractures. Twin and family studies have shown high heritability of bone mineral density (BMD) and other determinants of fracture risk such as ultrasound properties of bone, skeletal geometry, and bone turnover. Osteoporotic fractures also have a heritable component, but this reduces with age as environmental factors such as risk of falling come into play. Susceptibility to osteoporosis is governed by many different genetic variants and their interaction with environmental factors such as diet and exercise. Notable successes in identification of genes that regulate BMD have come from the study of rare Mendelian bone diseases characterized by major abnormalities of bone mass where variants of large effect size are operative. Genome-wide association studies have also identified common genetic variants of small effect size that contribute to regulation of BMD and fracture risk in the general population. In many cases, the loci and genes identified by these studies had not previously been suspected to play a role in bone metabolism. Although there has been extensive progress in identifying the genes and loci that contribute to the regulation of BMD and fracture over the past 15 yr, most of the genetic variants that regulate these phenotypes remain to be discovered.

Entities:  

Mesh:

Year:  2010        PMID: 20431112     DOI: 10.1210/er.2009-0044

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  117 in total

1.  Pathway analysis of genome-wide association study for bone mineral density.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-04-25       Impact factor: 2.316

2.  Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density.

Authors:  Carrie M Nielson; Joseph M Zmuda; Amy S Carlos; Wendy J Wagoner; Emily A Larson; Eric S Orwoll; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

Review 3.  Pharmacogenetics of osteoporosis: what is the evidence?

Authors:  Francesca Marini; Maria Luisa Brandi
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  Regulatory element-based prediction identifies new susceptibility regulatory variants for osteoporosis.

Authors:  Shi Yao; Yan Guo; Shan-Shan Dong; Ruo-Han Hao; Xiao-Feng Chen; Yi-Xiao Chen; Jia-Bin Chen; Qing Tian; Hong-Wen Deng; Tie-Lin Yang
Journal:  Hum Genet       Date:  2017-06-20       Impact factor: 4.132

5.  The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk.

Authors:  Youjin Wang; Jean Wactawski-Wende; Lara E Sucheston-Campbell; Leah Preus; Kathleen M Hovey; Jing Nie; Rebecca D Jackson; Samuel K Handelman; Rami Nassir; Carolyn J Crandall; Heather M Ochs-Balcom
Journal:  Am J Clin Nutr       Date:  2017-02-01       Impact factor: 7.045

Review 6.  Genetic profiling and individualized assessment of fracture risk.

Authors:  Tuan V Nguyen; John A Eisman
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

7.  Low mineral density of a weight-bearing bone among adult women in a high fertility population.

Authors:  Jonathan Stieglitz; Bret A Beheim; Benjamin C Trumble; Felicia C Madimenos; Hillard Kaplan; Michael Gurven
Journal:  Am J Phys Anthropol       Date:  2014-12-08       Impact factor: 2.868

Review 8.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

9.  Identification of a Core Module for Bone Mineral Density through the Integration of a Co-expression Network and GWAS Data.

Authors:  Olivia L Sabik; Gina M Calabrese; Eric Taleghani; Cheryl L Ackert-Bicknell; Charles R Farber
Journal:  Cell Rep       Date:  2020-09-15       Impact factor: 9.423

10.  Mutations in WNT1 cause different forms of bone fragility.

Authors:  Katharina Keupp; Filippo Beleggia; Hülya Kayserili; Aileen M Barnes; Magdalena Steiner; Oliver Semler; Björn Fischer; Gökhan Yigit; Claudia Y Janda; Jutta Becker; Stefan Breer; Umut Altunoglu; Johannes Grünhagen; Peter Krawitz; Jochen Hecht; Thorsten Schinke; Elena Makareeva; Ekkehart Lausch; Tufan Cankaya; José A Caparrós-Martín; Pablo Lapunzina; Samia Temtamy; Mona Aglan; Bernhard Zabel; Peer Eysel; Friederike Koerber; Sergey Leikin; K Christopher Garcia; Christian Netzer; Eckhard Schönau; Victor L Ruiz-Perez; Stefan Mundlos; Michael Amling; Uwe Kornak; Joan Marini; Bernd Wollnik
Journal:  Am J Hum Genet       Date:  2013-03-14       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.